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The addition of norepinephrine to perfused rat livers and to collagenase isolated hepatocytes induced a marked and dose-dependent magnesium 
efflux. The addition of ,Sadrenergic receptor antagonists, but not a-antagonists, completely blocked the Mgl+ e&x. The Mgs+ eflhrx could also 
be induced by forskolin and by permeable CAMP analogues. By contrast, the addition of carbachol or vasopressin induced a M&’ influx into 
isolated hepatocytes. These results indicate that a significant Mgl+ efflux from liver cells can be induced through the fi-adrenergic receptors and 
that it is mediated through the cytosolic CAMP levels. 
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1. INTRODUCTION 
Magnesium is one of the more abundant cations in- 
side cells [1,2] where it is involved as a cofactor in a 
variety of intracellular enzymatic processes [1,3-81 and 
as a stabilizer of membrane integrity [9]. Heretofore, a 
large body of information on Mg2+ transport has been 
obtained from bacteria [9-l l] and giant cells [9,12]. 
Yet little or inconsistent data are available in the 
literature about Mg2+ intracellular compartmentation 
[4,7,13] or Mg2+ mobilization in response to external 
stimuli [ 14-161 in mammalian cells. Changes in Mg2+ 
concentration have been observed in mitochondria in 
normal [7] or in stimulated conditions [8] and very 
recently attention has been directed to a possible Mg2+ 
movement in perfused livers [17] or hearts [ 181. 
glucose 10, NaHCOs 12, CaCls 1.25, MgCls 1.2 (pH 7.2 with Os/ 
CO2 95:5 by vol., 37°C). After 10 min the perfusion medium was 
switched to a similar perfusion medium containing 0 mM Mg’+. The 
flow was 20 ml/min without recirculation. Different doses of NE, 
agonists and antagonists were directly added in the perfusing medium 
as indicated. The effluent perfusate was collected every 15 s and the 
Mg’+ content of the perfusate measured by atomic absorbance spec- 
trophotometry (Varian AA-575). 
In the present study we report the presence of an 
Mg2+ flux across the plasma membrane of liver cells, 
both in perfused rat liver as well as in isolated 
hepatocytes. We also demonstrate that this movement 
is regulated via modulation of the cytosolic CAMP 
level. 
Hepatocytes isolated by collagenase digestion were prepared accor- 
ding to Seglen [19] and utilized up to 3-4 h after isolation. During 
this time the viability (85 f 3%, n = 9) did not change significantly. 
The hepatocytes were washed four times and incubated at a concen- 
tration of 100-150 fig protein/ml in the same medium in the absence 
of Mg2+ at 37°C. After the addition of the cells the Mg*+ present as 
contaminant in the incubation buffer, measured by atomic absor- 
bance spectrophotometry, ranged between 10 and ZOpM. After 
5 min of equilibration, in absence or presence of antagonists, 
adrenergic agonists were added. At the time indicated in the figures 
samples were withdrawn and centrifuged in microfuge tubes. The 
Mg*+ content of the supernatant was measured by atomic absorbance 
spectrophotometry. 
The protein was determined according to Bradford [20]. 
2.1. Chemicals 
Collagenase type CLS-1 was from Worthington Biochemical Corp. 
(Freehold, NJ, USA). All other chemical reagents and drugs were 
from Sigma (St. Louis, MO, USA), except Sotalol that was obtained 
from Bristol Myers Co. (Evansville, IN, USA). 
2. MATERIALS AND METHODS 
Male Sprague-Dawley rats (200-250 g) fed on stock diet were used 
as liver donors after anaesthetic treatment with intraperitoneal injec- 
tion of phentobarbital. Livers were removed and perfused with a 
medium containing (mM): NaCl 120, KC1 3, Hepes 10, KHsP04 1.2, 
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Fig. 1 shows the result of an experiment where Mg2+ 
content of the perfusate was measured in the absence 
(Fig. 1A) and in the presence (Fig. 1B) of 
norepinephrine (NE) stimulation. In order to increase 
the sensitivity of the Mg2+ measurements and to 
magnify Mg2+ efflux, 5 min before the measurements 
were carried out, the perfusion medium was changed to 
one containing 0 Mg2+. The collected perfusate was 
assayed as described in section 2. In the control liver 
(Fig. 1A) the Mg2+ efflux as measured as Mg2+ content 
of the perfusate was about 2,uM and continued 
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Fig. 1. Mg*+ efflux in control perfused rat liver (A) and after addition of norepinephrine (B). One experiment typical of three both for the control 
and norepinephrine (NE) stimulated livers is shown. 
throughout the perfusion period. By contrast, in the 
stimulated liver (Fig. IB) the addition of 1 pM 
norepinephrine (NE) evoked a large and reproducible 
Mg2+ efflux. Under the same experimental conditions, 
no detectable release of LDH was observed (not 
shown), indicating that the Mg2+ efflux was not secon- 
dary to plasma membrane damage and increase in 
permeability. 
To avoid possible interference from cell heterogenei- 
ty, perfusion rate and other metabolic conditions, the 
following experiments were carried out using col- 
lagenase dispersed hepatocytes. As shown in Fig. 2, the 
addition of NE at concentrations of 1 nM or 1 PM to 
a suspension of hepatocytes evoked an efflux of Mg2+ 
in the extracellular medium corresponding to a release 
of 6 and 10 nmol Mg’+/million cells, within 6 min, 
respectively. Qualitatively similar results were induced 
by the addition of the fl-adrenergic agonist 
isoproterenol (not shown). 
Because the targets of adrenergic stimulation are the 
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Fig. 2. Mg*’ efflux induced by different doses of norepinephrine on 
isolated hepatocytes. Where indicated 1 nM or 1 PM norepinephrine 
was added to a suspension of isolated hepatocytes. The data are 
means rt SE of 4 different preparations. 
cy and p receptor located in the plasma membrane of 
liver cells [21,22] we used both CY and p blockers 
[23-251 to identify the type of receptor involved in the 
regulation of Mg2+ efflux after adrenergic stimuli. The 
addition of 2 gM propranolol (a non-selective ,& 
antagonist) blocked the Mg2+ efflux induced by NE 
(Fig. 3). The inhibition lasted for at least 12 min after 
the addition of NE (not shown). In contrast, the addi- 
tion of a-blocker as regitine was far less effective 
(Fig. 3). Qualitatively similar responses were also ob- 
tained by using the &blocker, sotalol, or the cy- 
blockers, prazosin and yohimbine (not shown). 
Table I shows that the above Mg2+ efflux is depen- 
dent on an increase in cytosolic CAMP level. The addi- 
tion of 1 pM NE stimulates an Mg2+ efflux in the 
extracellular medium corresponding to approximately 
10 nmol Mg’+/million cells in 5 min. The addition of 
forskolin at a concentration directly activating 
adenylate cyclase [26], induced an Mg2+ efflux at an ex- 
tent similar to that obtained with NE. Virtually iden- 
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Fig. 3. Inhibition by a- and fl-adrenergic receptor blocking agents on 
the Mg’+ efflux induced by norepinephrine in isolated hepatocytes. 
Where indicated, 1 PM norepinephrine (NE) was added in the 
absence or presence of 2 PM regitine or 2 $M propranolol. The data 
are the means + SE of 4 different preparations. 
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Table I 
Effect of norepinephdne, forskolin and permeant CAMP analogues 
on Mgzf efflux in isolated hepatocytes 
Agent Extracellular Mg’+ content 
(nmot/million cells) 
Incubation time 
(min after addition) 
1 3 5 
Control 27.15 + 0.53 27.40 f 0.55 27.20 + 0.65 
1gMNE 32.78 t 0.70 35.27 + 0.67 37.50 f 0.55 
50 forskohn pm 31.25 i 0.75 33.75 f 1.10 38.05 + 1.80 
100 pM dBucAMP 30.78 rt 0.23 35.08 + 1.40 38.73 4 0.53 
100 PM 8C&AMP 33.53 f: 0.80 36.93 + 0.65 39.10 f 0.85 
250 /rM 8-Br-CAMP 32.98 it 0.48 36.70 + 0.75 39.40 + 0.35 
Data are means f SE of 10 experiments for control and 
norepinephrine (NE) stimulated cells and of 3 experiments for 
forskohn and cyclic-AMP analogues timulated cells, respectively 
tical Mg2+ movements were also observed after the 
addition of three different permeable CAMP analogues. 
By contrast Fig. 4 shows that the additions of 100 /cM 
carbachol or 10 nM vasopressin, substances able to in- 
hibit the adenylate cyclase activity via activation of Gi 
[27,28], stimulated a sizable cellular uptake of Mg’+. 
4. DISCUSSION 
The present data, obtained from perfused rat liver 
and isolated hepatocytes, indicate the presence of a new 
mechanism involved in Mg2+ transport across the 
plasma membrane of liver cells. Recently, Jakob et al. 
[ 171 have shown an Mg2” release in perfused liver in- 
duced by phenylephrine, via stimulation of the 
cui-adrenergic receptor. Our data show that the Mg2+ 
efflux from perfused liver and liver cells is occurring 
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Fig. 4. Fluxes of Mg2+ across isolated hepatocpes: stimulation of 
efflux by norepinephrine and of uptake by carbachol and 
vasopressin. Where indicated carrier (as control), 1 pM 
norepinephrine (NE), 100 PM carbachol or 10 nM vasopressin were 
added. The data are the means tt SE of 3 different preparations. 
through the adrenergic stimuiation of &receptors and 
that the net MgZf efflux is clearly related to the CAMP 
levels of the liver and hepatocytes. The decreased Mg*+ 
efflux we observed in presence of regitine could be ac- 
counted for by either a mobilization of Mg’+ after 
stimulation of (Y receptors 1171 or, more likely, to an 
absence of complete speci~city of regitine towards the 
a-receptors. 
The increase in cellular CAMP concentration via ,& 
adrenergic stimulation as well as the direct additions of 
permeable CAMP analogues or forskolin induce a con- 
sistent Mg2’ efflux through the plasma membrane of 
liver cells. Since our experiments were carried out at 
very low (uM) concentrations of external Mg2+, the 
presence of a concentration gradient between the inside 
and the outside of the cells may have resulted in an 
amplification of Mg2+ efflux. It is noteworthy that 
under those conditions, both vasopressin and carbachol 
were able to stimulate MgZf uptake against a concen- 
tration gradient. The action of vasopressin and car- 
bachol in liver cells is complex but a major effect is the 
decrease of cytosolic AMP levels [27,28]. Bond et al. 
[S] observed that the addition of vasopressin to rat liver 
in vivo resulted in an increase in the mitochondrial 
Mg2+ content. Therefore, it is possible that in our ex- 
perimental conditions a major intracellular redistribu- 
tion of Mg2+ is occurring in the cells. More specifically 
this could be consistent with an increase of Mg2+ 
transport across the mitochondrial inner membrane 
which should have a major effect on the mitochondrial 
choice of substrate utilization. 
In conclusion, our data show that there is an ap- 
parent correlation between CAMP levels in liver cells 
and net Mg2” efflux. The observed Mg2+ efflux could 
be the result of regulation by cyclic AMP of one or 
several Mgzf transport pathways in liver cells. A work- 
ing hypothesis, consistent with but not proven by the 
present data, is that there are at least two pathways 
operating Mg2+ fluxes in hepatocytes: one for Mg2+ ef- 
flux and one for Mg2+ influx, the latter being inhibited 
by CAMP. 
Many other experiments need to be carried out to 
define in more detail the mechanism(s) involved in 
Mg2+ transport and to examine a possible redistribu- 
tion of intracellular Mg2+ occurring after adrenergic 
and/or hormonal stimulations. 
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